UNTCHI’s work involves the identification of unknown decedents through mitochondrial DNA (mtDNA) and short tandem repeat (STR) analysis of remains with the assistance of anthropological and deontological analysis. A second component of its work is the development of a basis for the future identification of individuals reported missing through the DNA analysis of missing person samples and reference samples provided by families with a missing loved one. A third component of UNTCHI’s work is the development of the capacity to process large numbers of both human remains and family reference samples in a mass disaster event. The fourth component of the work is the delivery of educational services to the medical-legal community in order to nurture improved access and use of the UNTCHI and other qualified DNA testing facilities, as well as to promote the use of the National Missing and Unidentified System (Nam Us). A total of 639 agencies within 45 States have submitted samples to the UNTCHI. At the close of the current grant award, UNTCHI has received approximately 3,000 family reference samples, 1,339 samples from unidentified decedents, and 145 missing-person samples. UNTCHI has completed the analysis of 2,609 family reference samples, 51 missing person samples, and 1,020 unidentified human remains have been either completed or are near completion. As of April 2008, UNTCHI had uploaded 1,980 family reference samples and 661 unidentified human-remains samples into the National DNA Index System of CODIS. To date, grant-related work has resulted in a total of 195 confirmed identifications through DNA analysis of remains submitted from 35 States. 8 appendixes with supplementary information
Downloads
Similar Publications
- Missing persons: a national survey approach assessing the predictors of case outcomes
- Impact of age, sex, and size on the thermal tolerance of the adult black soldier fly (Diptera: Stratiomyidae)
- Evaluation of the long-term stability of select phenylacetylindole, cycloalkylindole, quinolinyl, and carboxamide synthetic cannabinoids using LC–MS-MS